Insulet Corp. Stock Advances 3.3%, Outperforms Peers

This article was automatically generated by Dow Jones using technology from Automated Insights.

Shares of Insulet Corp. rallied 3.3% to $139.81 on what proved to be an all-around mixed trading session for the stock market, with the Dow Jones Industrial Average rising 0.4% to 51,850.55 and the S&P 500 Index falling 0.1% to 7,807.24.

This was the stock's third consecutive day of gains.

Insulet Corp. closed 60.6% short of its 52-week high of $354.88, which the company achieved on November 20th.

The stock outperformed some of its peers, as Eli Lilly & Co. rose 0.3% to $1,182.62, DexCom Inc. rose 2.2% to $85.92, and Johnson & Johnson rose 0.88% to $263.73.

Trading volume totaled 1.3 million, compared to the 50-day average of 1.8 million.

Data source: Dow Jones Market Data, FactSet

(END) Dow Jones Newswires

October 12, 2026 16:35 ET (20:35 GMT)